K

K

KAARNIRANTA , Kai

Last name: KAARNIRANTA

First name: Kai

2019 (v1)

Publication

Metadata-only

Changes in ocular signs and symptoms in patients switching from bimatoprost-Timolol to tafluprost-Timolol eye drops: An open-label phase IV study

Bourne, Rupert Richard Alexander Kaarniranta, Kai Lorenz, Katrin

Objectives Bimatoprost-Timolol (bimatoprost 0.03%-Timolol 0.5% fixed-dose combination [FDC]) and tafluprost-Timolol (tafluprost 0.0015%-Timolol 0.5% FDC) eye drops are currently the only topical intraocular pressure (IOP)-reducing therapies available as preservative-free (PF) prostaglandin and timolol FDC. The aim of this study was to...

Uploaded on: April 14, 2023